CTOs on the Move

Hooper Holmes

www.hooperholmes.ca

 
Hooper Holmes is a data-driven leader in collecting personal health data and transforming it into useful information, which in turn, enables our customers to take actions that manage or reduce their risks and expenses. As the foremost provider of risk assessment services for the insurance industry, we are the only company that can provide insurers with ALL the services they need to reach their ultimate goal: complete policy medical exam, data collection, laboratory testing, inspection reports and underwriting services in the industry. Each year we arrange more medical exams than any other company and process millions of specimens in our ...
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

CRS Medical Technologies

CRS Medical Technologies is a New Berlin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biomedical International

Biomedical International is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aatru Medical

Aatru Medical, LLC (Aatru) is a privately-held medical device company specializing in technology development in negative pressure wound therapy for surgical incisions and chronic wounds. The Aatru NPSIMS™ represents a new and advanced technology in ultraportable devices that are designed for use on closed surgical incisions that produce low exudate.

United Seating and Mobility

United Seating and Mobility is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Earth City, MO. To find more information about United Seating and Mobility, please visit www.unitedseating.com

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.